HAIFA, Israel, Oct. 1, 2009 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced, that on September 23, 2009, it filed its Annual Report on Form 10-K with the SEC, which included an audit report by the company’s independent registered public accounting firm containing a going concern qualification. The company makes this announcement in compliance with NASDAQ Marketplace Rule 5250(b)(2). The company’s auditors had previously issued going concern opinions for its fiscal years 2008, 2007 and 2006, in addition to several prior years.
